Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Alternatively spliced proline-rich cassettes link WNK1 to aldosterone action
Ankita Roy, … , Olivier Staub, Arohan R. Subramanya
Ankita Roy, … , Olivier Staub, Arohan R. Subramanya
Published August 4, 2015
Citation Information: J Clin Invest. 2015;125(9):3433-3448. https://doi.org/10.1172/JCI75245.
View: Text | PDF
Research Article Nephrology

Alternatively spliced proline-rich cassettes link WNK1 to aldosterone action

  • Text
  • PDF
Abstract

The thiazide-sensitive NaCl cotransporter (NCC) is important for renal salt handling and blood-pressure homeostasis. The canonical NCC-activating pathway consists of With-No-Lysine (WNK) kinases and their downstream effector kinases SPAK and OSR1, which phosphorylate NCC directly. The upstream mechanisms that connect physiological stimuli to this system remain obscure. Here, we have shown that aldosterone activates SPAK/OSR1 via WNK1. We identified 2 alternatively spliced exons embedded within a proline-rich region of WNK1 that contain PY motifs, which bind the E3 ubiquitin ligase NEDD4-2. PY motif–containing WNK1 isoforms were expressed in human kidney, and these isoforms were efficiently degraded by the ubiquitin proteasome system, an effect reversed by the aldosterone-induced kinase SGK1. In gene-edited cells, WNK1 deficiency negated regulatory effects of NEDD4-2 and SGK1 on NCC, suggesting that WNK1 mediates aldosterone-dependent activity of the WNK/SPAK/OSR1 pathway. Aldosterone infusion increased proline-rich WNK1 isoform abundance in WT mice but did not alter WNK1 abundance in hypertensive Nedd4-2 KO mice, which exhibit high baseline WNK1 and SPAK/OSR1 activity toward NCC. Conversely, hypotensive Sgk1 KO mice exhibited low WNK1 expression and activity. Together, our findings indicate that the proline-rich exons are modular cassettes that convert WNK1 into a NEDD4-2 substrate, thereby linking aldosterone and other NEDD4-2–suppressing antinatriuretic hormones to NCC phosphorylation status.

Authors

Ankita Roy, Lama Al-Qusairi, Bridget F. Donnelly, Caroline Ronzaud, Allison L. Marciszyn, Fan Gong, Y.P. Christy Chang, Michael B. Butterworth, Núria M. Pastor-Soler, Kenneth R. Hallows, Olivier Staub, Arohan R. Subramanya

×

Figure 3

WNK1 is an aldosterone-induced protein.

Options: View larger image (or click on image) Download as PowerPoint
WNK1 is an aldosterone-induced protein.
(A) Location of epitopes for the...
(A) Location of epitopes for the 3 exon-specific anti-WNK1 antibodies used in the immunoblots below. The exon 1 antibody selectively recognizes L-WNK1, while the exon 12 and 28 antibodies detect both L- and KS-WNK1. (B) Nanomolar doses of aldosterone increased total WNK1 protein abundance in mpkCCDc14 cells over 4 hours. High-MW signals at approximatley 250 kDa, corresponding to L-WNK1 (L) and lower-MW species corresponding to KS-WNK1 and/or proteolytic fragments of L-WNK1 (bracket) are noted. (C) 100 nM aldosterone increased total WNK1 protein abundance over a 16-hour timecourse in mpkCCDc14 cells. (D) Total SPAK and phosphorylated SPAK/OSR1 abundance were also increased in the presence of aldosterone. The “S-motif” antibody detects regulatory domain phosphorylation at Ser373 of SPAK and Ser325 of OSR1, a marker of SPAK/OSR1 activation (3). n = 4; *P < 0.05 for both total SPAK and pSPAK/OSR1 by 1-Way ANOVA Dunnett’s post hoc comparison to the abundance at time zero. See also Supplemental Figure 3.

Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts